Global Molecular Diagnostics in Infectious Disease Testing Market Research Report 2024(Status and Outlook)
Report Overview
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.
This report provides a deep insight into the global Molecular Diagnostics in Infectious Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Molecular Diagnostics in Infectious Disease Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Molecular Diagnostics in Infectious Disease Testing market in any manner.
Global Molecular Diagnostics in Infectious Disease Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
BD
BioMerieux
Thermo Fisher Scientific
Roche
Siemens
Veridex
Luminex
GenMark Diagnostics
Qiagen
Genomix Biotech
BioTheranostics
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
Market Segmentation (by Application)
Hospitals
Clinics
Academic Institutes
Laboratories
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Diagnostics in Infectious Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.
This report provides a deep insight into the global Molecular Diagnostics in Infectious Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Molecular Diagnostics in Infectious Disease Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Molecular Diagnostics in Infectious Disease Testing market in any manner.
Global Molecular Diagnostics in Infectious Disease Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
BD
BioMerieux
Thermo Fisher Scientific
Roche
Siemens
Veridex
Luminex
GenMark Diagnostics
Qiagen
Genomix Biotech
BioTheranostics
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
Market Segmentation (by Application)
Hospitals
Clinics
Academic Institutes
Laboratories
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Molecular Diagnostics in Infectious Disease Testing Market
- Overview of the regional outlook of the Molecular Diagnostics in Infectious Disease Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Diagnostics in Infectious Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Molecular Diagnostics in Infectious Disease Testing
1.2 Key Market Segments
1.2.1 Molecular Diagnostics in Infectious Disease Testing Segment by Type
1.2.2 Molecular Diagnostics in Infectious Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Molecular Diagnostics in Infectious Disease Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Molecular Diagnostics in Infectious Disease Testing Sales by Manufacturers (2019-2024)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Molecular Diagnostics in Infectious Disease Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Molecular Diagnostics in Infectious Disease Testing Sales Sites, Area Served, Product Type
3.6 Molecular Diagnostics in Infectious Disease Testing Market Competitive Situation and Trends
3.6.1 Molecular Diagnostics in Infectious Disease Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Molecular Diagnostics in Infectious Disease Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Molecular Diagnostics in Infectious Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Type (2019-2024)
6.3 Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2019-2024)
6.4 Global Molecular Diagnostics in Infectious Disease Testing Price by Type (2019-2024)
7 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Diagnostics in Infectious Disease Testing Market Sales by Application (2019-2024)
7.3 Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Molecular Diagnostics in Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
8 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY REGION
8.1 Global Molecular Diagnostics in Infectious Disease Testing Sales by Region
8.1.1 Global Molecular Diagnostics in Infectious Disease Testing Sales by Region
8.1.2 Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Molecular Diagnostics in Infectious Disease Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Molecular Diagnostics in Infectious Disease Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Molecular Diagnostics in Infectious Disease Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Molecular Diagnostics in Infectious Disease Testing Basic Information
9.1.2 Abbott Molecular Diagnostics in Infectious Disease Testing Product Overview
9.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 BD
9.2.1 BD Molecular Diagnostics in Infectious Disease Testing Basic Information
9.2.2 BD Molecular Diagnostics in Infectious Disease Testing Product Overview
9.2.3 BD Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.2.4 BD Business Overview
9.2.5 BD Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
9.2.6 BD Recent Developments
9.3 BioMerieux
9.3.1 BioMerieux Molecular Diagnostics in Infectious Disease Testing Basic Information
9.3.2 BioMerieux Molecular Diagnostics in Infectious Disease Testing Product Overview
9.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.3.4 BioMerieux Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
9.3.5 BioMerieux Business Overview
9.3.6 BioMerieux Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Basic Information
9.4.2 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product Overview
9.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 Roche
9.5.1 Roche Molecular Diagnostics in Infectious Disease Testing Basic Information
9.5.2 Roche Molecular Diagnostics in Infectious Disease Testing Product Overview
9.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Siemens
9.6.1 Siemens Molecular Diagnostics in Infectious Disease Testing Basic Information
9.6.2 Siemens Molecular Diagnostics in Infectious Disease Testing Product Overview
9.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.6.4 Siemens Business Overview
9.6.5 Siemens Recent Developments
9.7 Veridex
9.7.1 Veridex Molecular Diagnostics in Infectious Disease Testing Basic Information
9.7.2 Veridex Molecular Diagnostics in Infectious Disease Testing Product Overview
9.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.7.4 Veridex Business Overview
9.7.5 Veridex Recent Developments
9.8 Luminex
9.8.1 Luminex Molecular Diagnostics in Infectious Disease Testing Basic Information
9.8.2 Luminex Molecular Diagnostics in Infectious Disease Testing Product Overview
9.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.8.4 Luminex Business Overview
9.8.5 Luminex Recent Developments
9.9 GenMark Diagnostics
9.9.1 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Basic Information
9.9.2 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product Overview
9.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.9.4 GenMark Diagnostics Business Overview
9.9.5 GenMark Diagnostics Recent Developments
9.10 Qiagen
9.10.1 Qiagen Molecular Diagnostics in Infectious Disease Testing Basic Information
9.10.2 Qiagen Molecular Diagnostics in Infectious Disease Testing Product Overview
9.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.10.4 Qiagen Business Overview
9.10.5 Qiagen Recent Developments
9.11 Genomix Biotech
9.11.1 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Basic Information
9.11.2 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product Overview
9.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.11.4 Genomix Biotech Business Overview
9.11.5 Genomix Biotech Recent Developments
9.12 BioTheranostics
9.12.1 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Basic Information
9.12.2 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product Overview
9.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.12.4 BioTheranostics Business Overview
9.12.5 BioTheranostics Recent Developments
10 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET FORECAST BY REGION
10.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast
10.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country
10.2.3 Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region
10.2.4 South America Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Molecular Diagnostics in Infectious Disease Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Molecular Diagnostics in Infectious Disease Testing by Type (2025-2030)
11.1.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Molecular Diagnostics in Infectious Disease Testing by Type (2025-2030)
11.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Application (2025-2030)
11.2.1 Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) Forecast by Application
11.2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Molecular Diagnostics in Infectious Disease Testing
1.2 Key Market Segments
1.2.1 Molecular Diagnostics in Infectious Disease Testing Segment by Type
1.2.2 Molecular Diagnostics in Infectious Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Molecular Diagnostics in Infectious Disease Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Molecular Diagnostics in Infectious Disease Testing Sales by Manufacturers (2019-2024)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Molecular Diagnostics in Infectious Disease Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Molecular Diagnostics in Infectious Disease Testing Sales Sites, Area Served, Product Type
3.6 Molecular Diagnostics in Infectious Disease Testing Market Competitive Situation and Trends
3.6.1 Molecular Diagnostics in Infectious Disease Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Molecular Diagnostics in Infectious Disease Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Molecular Diagnostics in Infectious Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Type (2019-2024)
6.3 Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2019-2024)
6.4 Global Molecular Diagnostics in Infectious Disease Testing Price by Type (2019-2024)
7 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Diagnostics in Infectious Disease Testing Market Sales by Application (2019-2024)
7.3 Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Molecular Diagnostics in Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
8 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY REGION
8.1 Global Molecular Diagnostics in Infectious Disease Testing Sales by Region
8.1.1 Global Molecular Diagnostics in Infectious Disease Testing Sales by Region
8.1.2 Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Molecular Diagnostics in Infectious Disease Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Molecular Diagnostics in Infectious Disease Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Molecular Diagnostics in Infectious Disease Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Molecular Diagnostics in Infectious Disease Testing Basic Information
9.1.2 Abbott Molecular Diagnostics in Infectious Disease Testing Product Overview
9.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 BD
9.2.1 BD Molecular Diagnostics in Infectious Disease Testing Basic Information
9.2.2 BD Molecular Diagnostics in Infectious Disease Testing Product Overview
9.2.3 BD Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.2.4 BD Business Overview
9.2.5 BD Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
9.2.6 BD Recent Developments
9.3 BioMerieux
9.3.1 BioMerieux Molecular Diagnostics in Infectious Disease Testing Basic Information
9.3.2 BioMerieux Molecular Diagnostics in Infectious Disease Testing Product Overview
9.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.3.4 BioMerieux Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
9.3.5 BioMerieux Business Overview
9.3.6 BioMerieux Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Basic Information
9.4.2 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product Overview
9.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 Roche
9.5.1 Roche Molecular Diagnostics in Infectious Disease Testing Basic Information
9.5.2 Roche Molecular Diagnostics in Infectious Disease Testing Product Overview
9.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Siemens
9.6.1 Siemens Molecular Diagnostics in Infectious Disease Testing Basic Information
9.6.2 Siemens Molecular Diagnostics in Infectious Disease Testing Product Overview
9.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.6.4 Siemens Business Overview
9.6.5 Siemens Recent Developments
9.7 Veridex
9.7.1 Veridex Molecular Diagnostics in Infectious Disease Testing Basic Information
9.7.2 Veridex Molecular Diagnostics in Infectious Disease Testing Product Overview
9.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.7.4 Veridex Business Overview
9.7.5 Veridex Recent Developments
9.8 Luminex
9.8.1 Luminex Molecular Diagnostics in Infectious Disease Testing Basic Information
9.8.2 Luminex Molecular Diagnostics in Infectious Disease Testing Product Overview
9.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.8.4 Luminex Business Overview
9.8.5 Luminex Recent Developments
9.9 GenMark Diagnostics
9.9.1 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Basic Information
9.9.2 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product Overview
9.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.9.4 GenMark Diagnostics Business Overview
9.9.5 GenMark Diagnostics Recent Developments
9.10 Qiagen
9.10.1 Qiagen Molecular Diagnostics in Infectious Disease Testing Basic Information
9.10.2 Qiagen Molecular Diagnostics in Infectious Disease Testing Product Overview
9.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.10.4 Qiagen Business Overview
9.10.5 Qiagen Recent Developments
9.11 Genomix Biotech
9.11.1 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Basic Information
9.11.2 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product Overview
9.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.11.4 Genomix Biotech Business Overview
9.11.5 Genomix Biotech Recent Developments
9.12 BioTheranostics
9.12.1 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Basic Information
9.12.2 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product Overview
9.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product Market Performance
9.12.4 BioTheranostics Business Overview
9.12.5 BioTheranostics Recent Developments
10 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET FORECAST BY REGION
10.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast
10.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country
10.2.3 Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region
10.2.4 South America Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Molecular Diagnostics in Infectious Disease Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Molecular Diagnostics in Infectious Disease Testing by Type (2025-2030)
11.1.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Molecular Diagnostics in Infectious Disease Testing by Type (2025-2030)
11.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Application (2025-2030)
11.2.1 Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) Forecast by Application
11.2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Molecular Diagnostics in Infectious Disease Testing Market Size Comparison by Region (M USD)
Table 5. Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Molecular Diagnostics in Infectious Disease Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2022)
Table 10. Global Market Molecular Diagnostics in Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Molecular Diagnostics in Infectious Disease Testing Sales Sites and Area Served
Table 12. Manufacturers Molecular Diagnostics in Infectious Disease Testing Product Type
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Molecular Diagnostics in Infectious Disease Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Molecular Diagnostics in Infectious Disease Testing Market Challenges
Table 22. Global Molecular Diagnostics in Infectious Disease Testing Sales by Type (K Units)
Table 23. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (M USD)
Table 24. Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Type (2019-2024)
Table 26. Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Molecular Diagnostics in Infectious Disease Testing Market Size Share by Type (2019-2024)
Table 28. Global Molecular Diagnostics in Infectious Disease Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) by Application
Table 30. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application
Table 31. Global Molecular Diagnostics in Infectious Disease Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Application (2019-2024)
Table 33. Global Molecular Diagnostics in Infectious Disease Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2019-2024)
Table 35. Global Molecular Diagnostics in Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Molecular Diagnostics in Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Region (2019-2024)
Table 38. North America Molecular Diagnostics in Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Molecular Diagnostics in Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Molecular Diagnostics in Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 44. Abbott Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 45. Abbott Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. BD Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 50. BD Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 51. BD Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. BD Business Overview
Table 53. BD Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 54. BD Recent Developments
Table 55. BioMerieux Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 56. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 57. BioMerieux Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. BioMerieux Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 59. BioMerieux Business Overview
Table 60. BioMerieux Recent Developments
Table 61. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 62. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 63. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Recent Developments
Table 66. Roche Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 67. Roche Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 68. Roche Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. Siemens Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 72. Siemens Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 73. Siemens Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Siemens Business Overview
Table 75. Siemens Recent Developments
Table 76. Veridex Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 77. Veridex Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 78. Veridex Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Veridex Business Overview
Table 80. Veridex Recent Developments
Table 81. Luminex Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 82. Luminex Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 83. Luminex Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Luminex Business Overview
Table 85. Luminex Recent Developments
Table 86. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 87. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 88. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. GenMark Diagnostics Business Overview
Table 90. GenMark Diagnostics Recent Developments
Table 91. Qiagen Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 92. Qiagen Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 93. Qiagen Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Qiagen Business Overview
Table 95. Qiagen Recent Developments
Table 96. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 97. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 98. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Genomix Biotech Business Overview
Table 100. Genomix Biotech Recent Developments
Table 101. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 102. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 103. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. BioTheranostics Business Overview
Table 105. BioTheranostics Recent Developments
Table 106. Global Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Molecular Diagnostics in Infectious Disease Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Molecular Diagnostics in Infectious Disease Testing Market Size Comparison by Region (M USD)
Table 5. Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Molecular Diagnostics in Infectious Disease Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2022)
Table 10. Global Market Molecular Diagnostics in Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Molecular Diagnostics in Infectious Disease Testing Sales Sites and Area Served
Table 12. Manufacturers Molecular Diagnostics in Infectious Disease Testing Product Type
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Molecular Diagnostics in Infectious Disease Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Molecular Diagnostics in Infectious Disease Testing Market Challenges
Table 22. Global Molecular Diagnostics in Infectious Disease Testing Sales by Type (K Units)
Table 23. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (M USD)
Table 24. Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Type (2019-2024)
Table 26. Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Molecular Diagnostics in Infectious Disease Testing Market Size Share by Type (2019-2024)
Table 28. Global Molecular Diagnostics in Infectious Disease Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) by Application
Table 30. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application
Table 31. Global Molecular Diagnostics in Infectious Disease Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Application (2019-2024)
Table 33. Global Molecular Diagnostics in Infectious Disease Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2019-2024)
Table 35. Global Molecular Diagnostics in Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Molecular Diagnostics in Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Region (2019-2024)
Table 38. North America Molecular Diagnostics in Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Molecular Diagnostics in Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Molecular Diagnostics in Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 44. Abbott Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 45. Abbott Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. BD Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 50. BD Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 51. BD Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. BD Business Overview
Table 53. BD Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 54. BD Recent Developments
Table 55. BioMerieux Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 56. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 57. BioMerieux Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. BioMerieux Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 59. BioMerieux Business Overview
Table 60. BioMerieux Recent Developments
Table 61. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 62. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 63. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Recent Developments
Table 66. Roche Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 67. Roche Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 68. Roche Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. Siemens Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 72. Siemens Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 73. Siemens Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Siemens Business Overview
Table 75. Siemens Recent Developments
Table 76. Veridex Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 77. Veridex Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 78. Veridex Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Veridex Business Overview
Table 80. Veridex Recent Developments
Table 81. Luminex Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 82. Luminex Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 83. Luminex Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Luminex Business Overview
Table 85. Luminex Recent Developments
Table 86. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 87. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 88. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. GenMark Diagnostics Business Overview
Table 90. GenMark Diagnostics Recent Developments
Table 91. Qiagen Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 92. Qiagen Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 93. Qiagen Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Qiagen Business Overview
Table 95. Qiagen Recent Developments
Table 96. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 97. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 98. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Genomix Biotech Business Overview
Table 100. Genomix Biotech Recent Developments
Table 101. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Basic Information
Table 102. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product Overview
Table 103. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. BioTheranostics Business Overview
Table 105. BioTheranostics Recent Developments
Table 106. Global Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Molecular Diagnostics in Infectious Disease Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Molecular Diagnostics in Infectious Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD), 2019-2030
Figure 5. Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD) (2019-2030)
Figure 6. Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Diagnostics in Infectious Disease Testing Market Size by Country (M USD)
Figure 11. Molecular Diagnostics in Infectious Disease Testing Sales Share by Manufacturers in 2023
Figure 12. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Manufacturers in 2023
Figure 13. Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Molecular Diagnostics in Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type
Figure 18. Sales Market Share of Molecular Diagnostics in Infectious Disease Testing by Type (2019-2024)
Figure 19. Sales Market Share of Molecular Diagnostics in Infectious Disease Testing by Type in 2023
Figure 20. Market Size Share of Molecular Diagnostics in Infectious Disease Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Molecular Diagnostics in Infectious Disease Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application
Figure 24. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Application in 2023
Figure 26. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2019-2024)
Figure 27. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application in 2023
Figure 28. Global Molecular Diagnostics in Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Country in 2023
Figure 32. U.S. Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Molecular Diagnostics in Infectious Disease Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Molecular Diagnostics in Infectious Disease Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Country in 2023
Figure 37. Germany Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Region in 2023
Figure 44. China Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 50. South America Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Country in 2023
Figure 51. Brazil Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Molecular Diagnostics in Infectious Disease Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Molecular Diagnostics in Infectious Disease Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Molecular Diagnostics in Infectious Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD), 2019-2030
Figure 5. Global Molecular Diagnostics in Infectious Disease Testing Market Size (M USD) (2019-2030)
Figure 6. Global Molecular Diagnostics in Infectious Disease Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Diagnostics in Infectious Disease Testing Market Size by Country (M USD)
Figure 11. Molecular Diagnostics in Infectious Disease Testing Sales Share by Manufacturers in 2023
Figure 12. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Manufacturers in 2023
Figure 13. Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Molecular Diagnostics in Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type
Figure 18. Sales Market Share of Molecular Diagnostics in Infectious Disease Testing by Type (2019-2024)
Figure 19. Sales Market Share of Molecular Diagnostics in Infectious Disease Testing by Type in 2023
Figure 20. Market Size Share of Molecular Diagnostics in Infectious Disease Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Molecular Diagnostics in Infectious Disease Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application
Figure 24. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Application in 2023
Figure 26. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2019-2024)
Figure 27. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application in 2023
Figure 28. Global Molecular Diagnostics in Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Country in 2023
Figure 32. U.S. Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Molecular Diagnostics in Infectious Disease Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Molecular Diagnostics in Infectious Disease Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Country in 2023
Figure 37. Germany Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Region in 2023
Figure 44. China Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 50. South America Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Country in 2023
Figure 51. Brazil Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Molecular Diagnostics in Infectious Disease Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Molecular Diagnostics in Infectious Disease Testing Market Share Forecast by Application (2025-2030)
